weight gain after tirzepatide Stopping GLP-1s: Regain and Maintenance Tips Myth Bust: Weight-Gain after GLP-1

A second study suggests the cardiovascular benefits of GLP-1 drugs may operate through mechanisms independent of weight reduction, a finding with potentially significant implications for how physicians manage patients on these medications

For example, a study of HepG2 cells 15 reports that GST P1-1 was catalyzing the release of NO from JS-K, in spite of the lack of detectable GST P1-1 protein in this cell line 16

This lipid accumulation leads to mitochondrial dysfunction, which in turn exacerbates HF 41

Mutation in a cells DNA, usually in multiple locations, is the primary cause of cells becoming cancerous

Little is known about the molecular mechanisms that causes these processes

PlexusDx also evaluates genetic markers in appetite regulation (FTO rs9939609, MC4R rs17782313) and melanocortin signaling that affect overall treatment tolerance